← Back to Clinical Trials
Recruiting NCT07138911

NCT07138911 Effect of Home-based Exercise Plan Mediated by Use of Digital Health App on Kinesiophobia and Functional Capacity

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07138911
Status Recruiting
Phase —
Sponsor Riphah International University
Condition Myocardial Infarction
Study Type INTERVENTIONAL
Enrollment 88 participants
Start Date 2025-08-13
Primary Completion 2026-02-20

Eligibility & Interventions

Sex All sexes
Min Age 30 Years
Max Age 55 Years
Study Type INTERVENTIONAL
Interventions
Intervention groupControl group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 88 participants in total. It began in 2025-08-13 with a primary completion date of 2026-02-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

To evaluate the effect of home-based exercise plan mediated by a digital health application on kinesiophobia and functional capacity in sedentary post myocardial infarction patients. Evidence suggest that digital health application significantly improve physical activity level in patient following cardiac event by providing personalized exercise plan, real time feed back, progress tracking and motivational features which enhanced adherence and engagement in rehabilitation program. This study could offer a viable le solution for overcoming barrier to rehabilitation particularly for those unable to access traditional clinic-based program

Eligibility Criteria

Inclusion Criteria: * 3 months post myocardial infarction patient * Sitting hours \>8 * IPAQ \< 600 Mets minutes Exclusion Criteria: * Unstable Angina * Recurrent Myocardial infarction * Recent surgery or Procedure * Heart failure, Arrhythmia

Contact & Investigator

Central Contact

Mehwish Waseem, MS-CPPT PhD*

✉ mehwish.waseem@riphah.edu.pk

📞 0331-5309015

Principal Investigator

Mehwish Waseem, MS-CPPT PhD*

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT07138911 clinical trial?

This trial is open to participants of all sexes, aged 30 Years or older, up to 55 Years, studying Myocardial Infarction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07138911 currently recruiting?

Yes, NCT07138911 is actively recruiting participants. Contact the research team at mehwish.waseem@riphah.edu.pk for enrollment information.

Where is the NCT07138911 trial being conducted?

This trial is being conducted at Islamabad, Pakistan.

Who is sponsoring the NCT07138911 clinical trial?

NCT07138911 is sponsored by Riphah International University. The principal investigator is Mehwish Waseem, MS-CPPT PhD* at Riphah International University. The trial plans to enroll 88 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology